Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001434265-26-000092
Filing Date
2026-06-15
Accepted
2026-06-15 12:08:43
Documents
7
Period of Report
2026-06-15

Document Format Files

Seq Description Document Type Size
1 6-K gmab_20260615x6kx2.htm 6-K 13815
2 EX-99.1 gmab_20260615xex99d1.htm EX-99.1 14993
3 EX-99.2 gmab_20260615xex99d2.htm EX-99.2 7621
4 GRAPHIC genmab_logo.jpg GRAPHIC 57250
5 GRAPHIC gmab_20260615xex99d2001.jpg GRAPHIC 143124
6 GRAPHIC gmab_20260615xex99d2002.jpg GRAPHIC 147846
7 GRAPHIC gmab_20260615xex99d2003.jpg GRAPHIC 52605
  Complete submission text file 0001434265-26-000092.txt   586459
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38976 | Film No.: 261089836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)